Area of research
Urology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Urinary Bladder and Prostate Research, Pelvic floor disorders treatments, Prostate Cancer Diagnosis and Treatment, and Prostate Cancer Treatment and Research.
Hengli® Chinese Botulinum Toxin Type A for Treatment of Patients With Overactive Bladder: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
Tumor‐derived exosomal <i>BCYRN1</i> activates WNT5A/VEGF‐C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer
Targeting WD repeat domain 5 enhances chemosensitivity and inhibits proliferation and programmed death-ligand 1 expression in bladder cancer
An oral methionine aminopeptidase II inhibitor for high-risk non-muscle invasive bladder cancer relapsed after intravesical therapies: Update of a phase II trial.
Results of a randomized, double‐blind, active‐controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladder